High materiality8/10
Acadia Pharmaceuticals price target lowered to $31 from $38 at Deutsche Bank
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Deutsche Bank lowers ACAD target to $31 from $38; current price $21.41.
- Target: $31; Price: $21.41; Firm: Deutsche Bank
Key facts
- 01
Target: $31
- 02
Posted price: $21.41
- 03
Analyst firm: Deutsche Bank
- 04
Analyst: David Hoang
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.